Source:

Press Release

January 02, 2021
1 min read
Save

Carbon22 receives FDA clearance of cannulated screw system for foot and ankle surgery

Source:

Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Carbon22, a company of GLW Inc., has received FDA 510(k) clearance to market the Creed cannulated screw system, a series of ortholucent bone screws for use in foot and ankle surgery, according to a press release.

The Creed cannulated screw portfolio includes a variety of novel headed and headless compression screws in a range of lengths. The screws are designed with radiotranslucent properties to improve visualization, according to the release.

“Unlike surgical systems that are used repeatedly in hundreds of surgical procedures, Carbon22’s Creed System ensures that every patient is treated with a sterile, single-use implant and new instruments functioning at their peak condition,” Axel Cremer, chief technology officer for Carbon22, said in the release.